Lessons from the neuropathology of atypical forms of multiple sclerosis

Neurological Sciences

Volumn 25, Issue SUPPL. 4, 2004, Pages

  Stadelmann, C ^a   Bruck W ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Acute disseminated encephalomyelitis; Concentric sclerosis; MS variants; Multiple sclerosis; Neuromyelitis optica

Indexed keywords

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CENTRAL NERVOUS SYSTEM; COMPLEMENT DEPENDENT CYTOTOXICITY; DEMYELINATING NEUROPATHY; DEMYELINATION; DIFFERENTIAL DIAGNOSIS; GLIOSIS; HUMAN; MACROPHAGE FUNCTION; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NERVE FIBER DEGENERATION; NEUROPATHOLOGY; OLIGODENDROGLIA; PATHOGENESIS; PELIZAEUS MERZBACHER DISEASE; POSTVACCINAL ENCEPHALITIS; REMYELINIZATION; SCHILDER DISEASE; SYSTEMATIC REVIEW; T LYMPHOCYTE; VIRUS HEMORRHAGIC FEVER;

DEMYELINATING DISEASES; DISEASE PROGRESSION; GLIOSIS; HUMANS; MULTIPLE SCLEROSIS;

EID: 10044279607     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-004-0333-1     Document Type: Article

References (32)

1. Lassmann H (1998) Pathology of multiple sclerosis. In: Compston A, Ebers G, Lassmann H, McDonald I, Matthews B, and Wekerle, H (eds) McAlpine's Multiple Sclerosis. Churchill Livingstone, London, pp 323-358
2. Prineas JW (1985) The neuropathology of multiple sclerosis. In: Koetsier JC (ed) Demyelinating Diseases. Elsevier Science Publishers, Amsterdam, pp 213-257
3. Allen IV (1991) Pathology of multiple sclerosis. In: Matthews WB (ed) McAlpine's Multiple Sclerosis. Churchill Livingstone, Edinburgh, pp 341-378
4. Brück W, Kuhlmann T, Stadelmann C (2003) Remyelination in multiple sclerosis. J Neurol Sci 206:181-185
5. Brück W, Lucchinetti C, Lassmann H (2002) The pathology of primary progressive multiple sclerosis. Mult Scler 8:93-97
6. Lassmann H, Brück W, Lucchinetti C (2001) Heterogeneity of multiple sclerosis pathogenesis: Implications for diagnosis and therapy. Trends Mol Med 7:115-121
7. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 47:707-717
8. Bitsch A, Brück W (2002) Differentiation of multiple sclerosis subtypes: Implications for treatment. CNS Drugs 16:405-418
9. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (1999) A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122:2279-2295
10. Bitsch A, Kuhlmann T, da Costa C, Bunkowski S, Polak T, Brück W (2000) Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: Correlation with demyelinating activity and oligodendrocyte pathology. Glia 29:366-375
11. Pitt D, Nagelmeier IE, Wilson HC, Raine CS (2003) Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. Neurology 61:1113-1120
12. Selmaj K, Cross AH, Farooq M, Brosnan CF, Raine CS (1991) Non-specific oligodendrocyte cytotoxicity mediated by soluble products of activated T cell lines. J Neuroimmunol 35:261-271
13. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP et al (1996) Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 184:2361-2370
14. Matysiak M, Jurewicz A, Jaskolski D, Selmaj K (2002) TRAIL induces death of human oligodendrocytes isolated from adult brain. Brain 125:2469-2480
15. Jurewicz A, Biddison WE, Antel JP (1998) MHC-Class Irestricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J Immunol 160:3056-3059
16. Merrill JE, Scolding NJ (1999) Review: Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease. Neuropathol Appl Neurobiol 25:435-458
17. Lassmann H, Brück W, Lucchinetti C, Rodriguez M (1997) Remyelination in multiple sclerosis. Mult Scler 3:133-136
18. Prineas JW, Connell F (1979) Remyelination in multiple sclerosis. Ann Neurol 5:22-31
19. Brück W, Schmied M, Suchanek G, Brück Y, Breitschopf H, Poser S, Piddlesden S, Lassmann H (1994) Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 35:65-73
20. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES (1993) Multiple Sclerosis: Remyelination of nascent lesions. Ann Neurol 33:137-151
21. Raine CS, Scheinberg L, Waltz JM (1981) Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Lab Invest 45:534-546
22. Marburg O (1906) Die sogenannte akute Multiple Sklerose (Encephalomyelitis periaxialis scleroticans). Jahrb Psychiat Neurol 27:213-312
23. Kastrup O, Stude P, Limmroth V (2002) Balóo's concentric sclerosis. Evolution of active demyelination demonstrated by serial contrast-enhanced MRI. J Neurol 249:811-814
24. Karaarslan E, Altintas A, Senol U,Yeni N, Dincer A, Bayindir C, Karaagac N, Siva A et al (2001) Baló's concentric sclerosis: clinical and radiologic features of five cases. AJNR Am J Neuroradiol 22:1362-1367
25. Yao D-L, Webster Hd, Hudson LD, Brenner M, Liu DS, Escobar AI, Komoly S (1994) Concentric sclerosis (Balóo): Morphometric and in situ hybridization study of lesions in six patients. Ann Neurol 35:18-30
26. Weinshenker BG (2003) Neuromyelitis optica: What it is and what it might be. Lancet 361:889-890
27. Baudoin D, Gambarelli D, Gayraud D, Bensa P, Nicoli F, Sudan N, Gastaut JL, Viallet F (1998) Devic's neuromyelitis optica: A clinicopathological review of the literature in connection with a case showing fatal dysautonomia. Clin Neuropathol 17:175-183
28. Lucchinetti CF, Mandler RN, McGavern D , Brück W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125:1450-1461
29. Nakashima I, Fujihara K, Fujimori J, Narikawa K, Misu T, Itoyama Y (2004) Absence of IgG1 response in the cerebrospinal fluid of relapsing neuromyelitis optica. Neurology 62:144-146
30. Hartung HP, Grossman RI (2001) ADEM. Distinct disease or part of the MS spectrum? Neurology 56:1257-1260
31. Hart MN, Earle KM (1975) Haemorrhagic and perivenous encephalitis: A clinico-pathological review of 38 cases. J Neurol Neurosurg Psychiatry 38:585-591
32. van Bogaert L (1950) Post-infectious encephalomyelitis and multiple sclerosis. The significance of perivenous encephalomyelitis. J Neuropathol Exp Neurol 9:219-249